Invesaro

Stocks INVZ Financial statements

Financial statements

Innoviz Technologies Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Innoviz Technologies Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Revenue0.061.58-9.365.476.0320.924.355.1
Cost of revenue0.051.996.4110.514.832.525.442.2
Gross profit0.01-0.41-15.8-5.02-8.76-11.6-1.1612.9
Research and development48.359.45793.395.192.773.856.5
Selling and marketing5.516.485.4323.710.38.787.475.75
General and administrative2.443.193.7535.619.219.519.518.4
Operating expenses56.36966.215312512110180.6
Operating income-56.3-69.5-82-158-133-133-102-67.7
Pre-tax income-56.4-67.3-81.3-153-127-123-94.6-67.6
Income tax0.030.010.180.280.330.640.170.17
Net income-56.4-67.3-81.5-154-127-123-94.8-67.8
EBITDA-55.6-67.8-79.3-154-126-123-94.1-61.9
EPS, basic-4.14-5.22-5.99-1.54-0.94-0.84-0.57-0.34
EPS, diluted-4.14-5.22-5.99-1.54-0.94-0.84-0.57-0.34
Shares, basic (weighted)1515.516.5103135147167200
Shares, diluted (weighted)1515.516.5103135147167200

Balance sheet

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents18.672.85023.655.726.325.48.64
Short-term investments011.641.713.3129.47
Receivables1.022.510.511.767.46.049.98
Inventory1.342.164.264.241.871.913.34
Other current assets1.923.293.033.245.776.714.78
Total current assets11257.927418816082.690.2
Property, plant and equipment11.313.214.530.525.823.419.9
Lease right-of-use assets026.925.523.225.1
Long-term investments038.37.844.810
Other non-current assets0.10.5400.080.080.080.09
Total assets12472.6327255219132138
Accounts payable7.157.755.768.378.048.818.6
Accrued liabilities3.372.545.176.177.784.614.74
Deferred revenue0.461.660.24.086.950.271.85
Short-term debt0.250.28
Total current liabilities14.717.821.732.437.227.831.4
Long-term debt2.332.220
Lease liabilities030.228.525.329.3
Other non-current liabilities00.60
Total liabilities27029628.463.465.953.160.7
Total debt2.572.50
Paid-in capital4.187.66684704789809876
Retained earnings-150-231-385-512-635-730-798
Shareholders' equity-80.7-146-22429919215378.977.7
Total equity-80.7-146-22429919215378.977.7
Total liabilities and equity12472.6327255219132138
Shares outstanding15.916.9134136165169214

Cash flow statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Net income-56.4-67.3-81.5-154-127-123-94.8-67.8
Depreciation and amortization0.661.672.663.967.479.197.795.87
Stock-based compensation1.382.173.264.719.422.319.716
Change in receivables-0.06-1.06-1.491.99-1.25-5.631.35-6.85
Change in inventory-1.14-0.2-0.82-2.090.022.37-0.040.24
Cash from operations-39.4-69.2-61.9-82.5-93.4-93.1-77-47.9
Capital expenditures-6.85-5.85-5.12-3.78-22.6-6.58-4.41-4.25
Purchases of investments00-104-30.1-51.7-55.5-37.6
Sales and maturities of investments53.930.183.562.240.3
Cash from investing40.2-40.629.6-2821251.0675.5-21.4
Debt issued0.582.0200
Debt repaid0-0.2-0.28-2.6400
Stock issued0.010.070.280.950.610.460.220.84
Cash from financing0.591638.943370.6161.90.2251.5
Exchange rate effect-0.610.90.750.72-1.140.520.311.12
Net change in cash0.7654.2-22.7-26.231.4-29.6-0.96-16.7
Free cash flow-46.2-75.1-67.1-86.3-116-99.6-81.4-52.2
Interest paid0.030.090.090.0900
Income taxes paid0.030.010.090.240.130.70.230.3

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.39 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin23.4%Gross profit / revenue.
Operating margin-123.0%Operating income / revenue.
EBITDA margin-112.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-122.8%Pre-tax income / revenue.
Net margin-123.1%Net income / revenue.
FCF margin-94.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-87.0%Cash from operations / revenue.
Return on equity (ROE)-86.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-50.1%Net income / average total assets.
Return on invested capital (ROIC)-87.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue102.5%Research and development expense / revenue.
Stock-based pay / revenue29.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue7.7%Capital expenditures / revenue.
D&A / revenue10.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y127.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y109.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y-1.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-26.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y4.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-18.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y13.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y19.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y13.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y64.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.87xCurrent assets / current liabilities.
Quick ratio0.89x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.58x(Cash + short-term investments) / current liabilities.
Liabilities / assets43.9%Total liabilities / total assets.
Working capital$58.8MCurrent assets - current liabilities.
Tangible book value$77.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.41xRevenue / average total assets.
Fixed asset turnover2.55xRevenue / average property, plant and equipment.
Inventory turnover16.1xCost of revenue / average inventory.
Days inventory23 days365 x average inventory / cost of revenue.
Receivables turnover6.88xRevenue / average receivables.
Days sales outstanding53 days365 x average receivables / revenue.
Days payables75 days365 x average accounts payable / cost of revenue.
Cash conversion cycle0 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.34Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.34Net income per basic share, as reported (split-adjusted).
Revenue per share$0.28Revenue / diluted weighted shares.
FCF per share-$0.26Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.24Cash from operations / diluted weighted shares.
Book value per share$0.36Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.36Tangible book value / shares outstanding.
Cash per share$0.08(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$136.6MShare price x shares outstanding.
Enterprise value$118.5MMarket cap + total debt - cash - short-term investments.
P/S2.48xMarket cap / revenue.
P/B1.76xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.76xMarket cap / tangible book value, when positive.
EV/Sales2.15xEnterprise value / revenue.
FCF yield-38.2%Free cash flow / market cap.
Earnings yield-49.6%Net income / market cap (the inverse of P/E).
What was Innoviz Technologies Ltd.'s revenue in fiscal 2025?

Innoviz Technologies Ltd. reported revenue of $55.1M for fiscal 2025, 127% higher than the year before.

Was Innoviz Technologies Ltd. profitable in fiscal 2025?

No. It reported a net loss of $67.8M.

How much free cash flow did Innoviz Technologies Ltd. generate in fiscal 2025?

Cash from operations of $47.9M minus capital expenditures of $4.3M left free cash flow of -$52.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Innoviz Technologies Ltd.